HCC
Showing 1 - 25 of 2,639
Study of Serum Tumor Markers of HBV Associated HCC
Not yet recruiting
- HCC
- tumor tissue and blood tests
- (no location specified)
Apr 10, 2023
HCC, Liver Cirrhosis Trial (sequential adult left lateral lobe liver transplantation (SALT))
Not yet recruiting
- HCC
- Liver Cirrhosis
- sequential adult left lateral lobe liver transplantation (SALT)
- (no location specified)
Oct 3, 2023
Carcinoma, Hepatocellular, Metabolic Syndrome Trial in Lecce (Liver resection and simultaneous sleeve gastrectomy for HCC
Recruiting
- Carcinoma, Hepatocellular
- Metabolic Syndrome
- Liver resection and simultaneous sleeve gastrectomy for HCC induced by metabolic syndrome
- Liver resection for HCC induced by metabolic syndrome
-
Lecce, ItalyOspedale Vito Fazzi
Sep 23, 2023
circRNAs (hsa_circ_0004001) in Early Diagnosis of HCC
Not yet recruiting
- Hepatic Cell Carcinoma
- (no location specified)
Sep 12, 2023
A New Conception About Individualized Treatment Allocation for
Completed
- HCC
- +2 more
- TACE
- (no location specified)
Aug 22, 2023
Advanced HCC, Other Solid Tumors Trial in Shanghai (KD6001, Tislelizumab, Bevacizumab)
Not yet recruiting
- Advanced HCC
- Other Solid Tumors
- KD6001
- +2 more
-
Shanghai, ChinaZhongshan Hospital
Jun 13, 2023
Hepatocellular Carcinoma Trial in Vienna (FMT combined with Atezolizumab plus Bevacizumab)
Not yet recruiting
- Hepatocellular Carcinoma
- FMT combined with Atezolizumab plus Bevacizumab
-
Vienna, AustriaMedical University of Vienna
Feb 19, 2023
Early Diagnosis of Hepatocellular Carcinoma (HCC)
Recruiting
- HCC
- +4 more
- Biomarker dosage
-
Castellana Grotte, Bari, ItalyRCCS "Saverio de Bellis"
Mar 23, 2023
EOB-MRI Guided Microwave Ablation for Early HCC: A Multicenter,
Active, not recruiting
- Early Hepatocellular Carcinoma
- MWA
-
Jinan, ChinaShandong PH
Oct 23, 2023
17-009: Multi-Institutional Study Examining HCC Undergoing Liver
Active, not recruiting
- Hepatocellular Carcinoma
-
Cleveland, Ohio
- +1 more
Aug 29, 2023
Liver Tumors Trial in Beijing (Tislelizumab plus tyrosine kinase inhibitor)
Recruiting
- Liver Neoplasms
- Tislelizumab plus tyrosine kinase inhibitor
-
Beijing, Beijing, China302 Hospital
Sep 22, 2023
Long Non-coding RNA SNHG15 asNovel Biomarker in HBV Associated
Not yet recruiting
- HCC
- No intervention was required for patients or control group in this study
- (no location specified)
Apr 21, 2023
Hepatocellular Carcinoma, Hepatocellular Carcinoma Non-resectable, Liver Cancer Trial (EYE90 Microspheres Treatment)
Not yet recruiting
- Hepatocellular Carcinoma
- +2 more
- EYE90 Microspheres Treatment
- (no location specified)
Jul 12, 2023
CT Perfusion Parameters for Advanced HCC Treated by Systemic
Completed
- Advanced HCC Treated by Systemic Immunotherapy
-
Nancy, FranceCHRU Nancy
Oct 13, 2022
Prognostic Models for HCC Based on Tumor Micronecrosis
Recruiting
- Hepatocellular Carcinoma
- observing whether HCC patients having tumor micronecrosis
-
Hangzhou, Zhejiang, Chinathe First Affiliated Hospital, School of Medicine, Zhejiang Univ
Apr 27, 2023
Postoperative Outcomes in Chinese HCC Patients Treated With
Recruiting
- Hepatocellular Carcinoma
-
Shanghai, Shanghai, ChinaZhongshan Hospital, Fudan University
Aug 1, 2023
Cell-free DNA From Junction of Hepatitis B Virus Integration in
Active, not recruiting
- Hepatocellular Carcinoma
-
Taipei, TaiwanNational Taiwan University Hospital
Apr 10, 2023
Hepatocellular Carcinoma, BCLC Stage B Hepatocellular Carcinoma Trial (Atezolizumab Injection, Bevacizumab, Transarterial
Not yet recruiting
- Hepatocellular Carcinoma
- BCLC Stage B Hepatocellular Carcinoma
- Atezolizumab Injection
- +2 more
- (no location specified)
Mar 16, 2023
ALBI and PALBI Scores and HCC Prognosis
Completed
- Hepatocellular Carcinoma (HCC) Prognosis
- ALBI
-
Sohag, EgyptSohag University
Jan 30, 2023
Severity of Liver Disease and Development of HCC in Cirrhotic
Not yet recruiting
- HCC
- (no location specified)
Jul 22, 2022
Liver Cancer Trial in Kansas City (Stereotactic Body Radiation Treatment)
Not yet recruiting
- Liver Cancer
- Stereotactic Body Radiation Treatment
-
Kansas City, KansasUniversity of Kansas Medical Center
Feb 13, 2023
Hepatocellular Carcinoma (HCC) Trial in Beijing (¹³C-Octanoate Breath Test)
Completed
- Hepatocellular Carcinoma (HCC)
- ¹³C-Octanoate Breath Test
-
Beijing, China
- +1 more
Dec 19, 2022
Hepatocellular Carcinoma, Surgery Trial (Autotransfusion)
Not yet recruiting
- Hepatocellular Carcinoma
- Surgery
- Autotransfusion
- (no location specified)
Nov 9, 2022
Hepatectomy for Early-stage HCC Patients With CSPH
Completed
- HCC
- Portal Hypertension
- hepatectomy
- (no location specified)
May 30, 2022